Viral vector manufacturing involves producing viral vectors used in gene therapy and cell therapy to deliver therapeutic genes into patient cells. The global viral vector manufacturing market size was valued at USD 267.8 million in 2024 and is expected to grow from USD 336.36 million in 2025 to USD 3189.15 million by 2033, growing at a CAGR of 19.7% during the forecast period...
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek